Brussels, 5 April 2016 – Members of the Alliance for Biomedical Research in Europe (BioMed Alliance) have approved the Code of Conduct of healthcare professionals and scientific organizations. The BioMed Alliance Code of Conduct sets out core principles to maintain and enhance professional independence, objectivity and scientific integrity.
The BioMed Alliance Code of Conduct also helps to ensure that the Alliance’s interactions and collaborations with the healthcare sector are for the benefit of patients and for the improvement of scientific standards and medical care.
The BioMed Alliance Code of Conduct oversees aspects of healthcare professionals and healthcare organisations’ relationship with industry and stakeholders. These include continuous medical education, professional development, scientific meetings, exhibition at congresses and research funding.
“The BioMed Alliance Code of Conduct sets high ethical standards and responds to the evolving demands of society. It is imperative that our activities are conducted transparently and with integrity for the benefit of patients” said Professor Colm O’Morain, President of the Alliance for Biomedical Research in Europe.
The BioMed Alliance Code of Conduct is the outcome of tremendous effort of the Alliance‘s members in collaboration with stakeholders in order to ensure that the biomedical research community’s voice is heard and understood.
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter